Learning Center >
Expert Insights
The risks of compounded GLP-1 medications
Form Health Chief Medical Officer, Dr. Florencia Halperin, provides insights into the risks associated with compounded weight loss medications and the clinical rationale for prioritizing comprehensive obesity management programs that integrate FDA-approved treatments with behavioral changes, nutrition, and lifestyle interventions. Watch as she explains why this approach not only ensures patient safety but also leads to better outcomes for individuals and payers.
Let’s get to work
No matter your size, industry, or population, we can help your organization form a healthier future.